Ignite Creation Date:
2025-12-25 @ 2:49 AM
Ignite Modification Date:
2026-06-24 @ 5:08 AM
Study NCT ID:
NCT05074433
Status:
TERMINATED
Last Update Posted:
2025-10-17
First Post:
2021-10-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults
Sponsor:
Regeneron Pharmaceuticals
Organization: